Company
NeoChord
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation.
Also known as NeoChord, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Maple Grove, MN, United States
- Legal name
- NeoChord, Inc
- neochord.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation.
Funding snapshot
- Total raised
- $77.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $32M2019-04-23
Funding rounds
- Round, 2025
- $493K2025-02-27, SEC form D sold, 14 investors
- Round, 2024
- $914K2024-08-16, SEC form D sold, 9 investors
- Round, 2023
- $4.6M2023-06-20, SEC form D sold, 3 investors
- Round, 2022
- $2.9M2022-09-08, SEC form D sold, 25 investors
- Round, 2022
- $1.8M2022-02-23, SEC form D sold, 6 investors
- Round, 2021
- $1M2021-09-10, SEC form D sold, 6 investors
- Round, 2021
- $2.8M2021-04-27, SEC form D sold, 6 investors
- Series D
- $32M2019-04-23, Company stated
- Series D
- $25M2018-11-05, Company stated
- Round, 2018
- $33.4M2018-10-31, SEC form D sold, 28 investors
- Round, 2017
- $4M2017-09-01, SEC form D sold, 27 investors
- Round, 2015
- $12.6M2015-05-11, SEC form D sold, 16 investors
- Round, 2015
- $457K2015-02-02, SEC form D sold, 10 investors
- Round, 2013
- $3M2013-03-05, SEC form D sold, 23 investors
- Round, 2012
- $852K2012-12-05, SEC form D sold, 10 investors
- More rounds
- 3 earlier rounds recorded
Products
- Hardware
- NeoChord Artificial Chordae Delivery System
Loading relationship preview